Evolus
EOLS
#7574
Rank
NZ$0.87 B
Marketcap
NZ$13.20
Share price
2.93%
Change (1 day)
18.21%
Change (1 year)

Earnings for Evolus (EOLS)

Earnings in 2026 (TTM): -NZ$58.54 Million

According to Evolus 's latest financial reports the company's current earnings are NZ$0.31 Billion. In 2025 the company made an earning of -NZ$91.28 Million a decrease over its 2024 earnings that were of -NZ$89.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Evolus from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$58.54 Million-35.87%
2025 -NZ$91.28 Million2.43%
2024 -NZ$89.12 Million-19.11%
2023 -NZ$0.12 Billion-17.23%
2022 -NZ$0.14 Billion59.02%
2021 -NZ$83.71 Million-71.32%
2020 -NZ$0.3 Billion55.09%
2019 -NZ$0.19 Billion124.48%
2018 -NZ$83.83 Million298.96%
2017 -NZ$21.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.28 Billion 363.60%๐Ÿ‡บ๐Ÿ‡ธ USA